Indivumed Services

Indivumed Services is now a fully integrated part of Crown Bioscience. For future updates, please follow the Crown Bioscience LinkedIn profile. Learn more about Crown Bioscience https://www.crownbio.com/

🎉 Happy New Year! To all our clients, partners, and colleagues, we wish you a fantastic year ahead! As we step into 2025, let's reflect on our shared responsibility: using our unique expertise and skill sets to work toward individualized cancer diagnosis and treatment for every patient.

As 2024 comes to a close, we wanted to take a moment to express our heartfelt gratitude and appreciation for all of our customers. We look forward to continuing our partnerships with clients in 2025 as we progress individualized cancer diagnosis and treatment for every patient. We are grateful to have such talented and dedicated clients, partners, and colleagues. Wishing you and your loved ones a wonderful holiday season, filled with joy and laughter.

Get to know Indivumed Services, your partner for biomarker discovery and drug and CDx development to realize personalized oncology. In this edition of Supplier Spotlight®, we asked them a few questions about their service offerings, what problems they help solve, new product and service developments & more. Read the full blog post now: https://lnkd.in/gQNxqWU8 Crown Bioscience

🥸Movember is over and we wanted to send a shoutout to our amazing colleagues who took on the challenge this year! Thank you for growing those moustaches and being champions for such a vital cause! Heinz Joachim List Martin Bodenburg-Luebcke Christopher Günther Dr. Malik Khenkhar Louis Nickels Seyedali Memari

Happy Thanksgiving! 🦃 We want to express our sincere gratitude to all of our colleagues, clients, and partners. You are the reason why we exist and thrive. You have made this year a remarkable one for us. Thank you for your dedication, loyalty, and trust.

Continuing our focus on Lung Cancer Awareness Month, we're sharing innovative research from our scientific poster showcasing promising new insights into potential treatments. Using cutting-edge spatial transcriptomics, we analyzed the effects of therapeutic compounds on non-small cell lung cancer (NSCLC) tissue slices. This advanced technique allows us to map gene expression within the tumor microenvironment, revealing crucial details about cellular interactions and tumor heterogeneity. By visualizing how treatments impact different cell types within NSCLC, our research uncovers the mechanisms of action behind potential drugs, providing valuable information on drug efficacy and safety. This research brings us one step closer to developing more precise and personalized therapies. Download the poster: https://hubs.la/Q02YTCqy0

Day 2 at AACR’s Special Conference in Cancer Research: Liquid Biopsy: From Discovery to Clinical Implementation. If you’re also attending, feel free to reach out to me or my colleague Sadaf M. — we’d love to connect! #AACR #LiquidBiopsy #CancerResearch #IndivumedServices #CrownBiocience

Excited to be attending AACR’s Special Conference in Cancer Research alongside my colleague Cynthia O'Neill, PMP where we’re exploring the latest advancements in liquid biopsy from discovery to clinical implementation. If you’re also attending, feel free to reach out—we’d love to connect! #AACR #LiquidBiopsy #CancerResearch #IndivumedServices

We are a 10x Genomics Certified Service Provider for spatial gene expression solutions, so you can depend on our spatial transcriptomics services. These solutions allow for the mapping of gene expression data to specific locations within a tissue section, preserving the native architecture of the tissue. Listen to a short clip from Dr. Nicole Kerstedt on Visium Transcriptomics as she describes on how advanced platforms can streamline your research and receive a thorough overview of spatial transcriptomics, including how transcriptional changes can inform drug treatment decisions. Watch the whole webinar on-demand ➡️ https://hubs.la/Q02Y1r3g0